EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole

Aldona Minecka iD, Magdalena Tarnacka iD, Karolina Jurkiewicz iD, Daniel Żakowiecki, Kamil Kamiński iD, Ewa Kamińska iD

Molecular Pharmaceutics · 2023

DOI: 10.1021/acs.molpharmaceut.3c00524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Aldona Minecka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy and Phytochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 So…. Hauptthemen laut MEDLINE: Drug Carriers, Silicon Dioxide. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Narodowe Centrum Badan i Rozwoju.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The enhancement of the properties (i.e., poor solubility and low bioavailability) of currently available active pharmaceutical ingredients (APIs) is one of the major goals of modern pharmaceutical sciences. Among different strategies, a novel and innovative route to reach this milestone seems to be the application of nanotechnology, especially the incorporation of APIs into porous membranes composed of pores of nanometric size and made of nontoxic materials. Therefore, in this work, taking the antipsychotic API aripiprazole (APZ) infiltrated into various types of mesoporous matrices (anodic aluminum oxide, native, and silanized silica) characterized by similar pore diameters (d = 8-10 nm) as an example, we showed the advantage of incorporated systems in comparison to the bulk substance considering the crystallization kinetics, molecular dynamics, and physical stability. Calorimetric investigations supported by the temperature-dependent X-ray diffraction measurements revealed that in the bulk system the recrystallization of polymorph III, which next is converted to the mixture of forms IV and I, is visible, while in the case of confined samples polymorphic forms I and III of APZ are produced upon heating of the molten API with different rates. Importantly, the two-step crystallization observed in thermograms obtained for the API infiltrated into native silica templates may suggest crystal formation by the interfacial and core molecules. Furthermore, dielectric studies enabled us to conclude that there is no trace of crystallization of spatially restricted API during one month of storage at T = 298 K. Finally, we found that in contrast to the crystalline and amorphous bulk samples, all examined confined systems show a logarithmic increase in API dissolution over time (very close to a prolonged release effect) without any sign of precipitation. Our data demonstrated that mesoporous matrices appear to be interesting candidates as carriers for unstable amorphous APIs, like APZ. In addition to protecting them against crystallization, they can provide the desired prolonged release effect, which may increase the drug concentration in the blood (resulting in higher bioavailability). We believe that the "nanostructirization" in terms of the application of porous membranes as a novel generation of drug carriers might open unique perspectives in the further development of drugs characterized by prolonged release.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CarriersSilicon DioxideAripiprazoleSolubilityCrystallizationPharmaceutical Preparations

Stichwörter der Autor:innen

aripiprazolecrystallizationdissolution ratedrug carriermesoporespolymorphic forms

Substanzen

AripiprazoleDrug CarriersSilicon DioxidePharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Pharmacognosy and Phytochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.
  • A. Chelkowski Institute of Physics, University of Silesia in Katowice, 41-500 Chorzow, Poland.
  • Chemische Fabrik Budenheim KG, Rheinstrasse 27, 55257 Budenheim, Germany.

ORCID-Profile: Aldona Minecka, Magdalena Tarnacka, Karolina Jurkiewicz, Kamil Kamiński, Ewa Kamińska

Förderung

  • Narodowe Centrum Nauki
  • Narodowe Centrum Badan i Rozwoju

Zitieren

APA

Minecka, A., Tarnacka, M., Jurkiewicz, K., Żakowiecki, D., Kamiński, K., & Kamińska, E. (2023). Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00524

Vancouver

Minecka A, Tarnacka M, Jurkiewicz K, Żakowiecki D, Kamiński K, Kamińska E. Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00524

BibTeX
@article{Minecka2023,
  author = {Minecka, Aldona and Tarnacka, Magdalena and Jurkiewicz, Karolina and Żakowiecki, Daniel and Kamiński, Kamil and Kamińska, Ewa},
  title = {Mesoporous Matrices as a Promising New Generation of Carriers for Multipolymorphic Active Pharmaceutical Ingredient Aripiprazole},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  doi = {10.1021/acs.molpharmaceut.3c00524}
}
Kostenlos starten →